Skip to main content
. Author manuscript; available in PMC: 2008 Mar 17.
Published in final edited form as: Breast Cancer Res Treat. 2007 May 17;108(1):43–55. doi: 10.1007/s10549-007-9587-7

Fig. 4.

Fig. 4

Dual-level targeting allows specific 5′-UTR-E1A mRNA translation during CRAd infection. Western blot analysis was performed using lysates from normal cells expressing relatively low levels of eIF4E (A) and breast cancer cell lines expressing relatively high levels of eIF4E (B) after infection with after infection with Ad-CXCR4-E1A, Ad-CXCR4-UTR-E1A, Ad-CXCR4-GL3 (negative control) or Ad-wt-dE3 (positive control).